These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 3326466)

  • 1. Induction of transformed cells to terminal differentiation.
    Marks PA; Sheffery M; Ramsay R; Ikeda K; Rifkind RA
    Ann N Y Acad Sci; 1987; 511():246-55. PubMed ID: 3326466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in gene expression during hexamethylene bisacetamide induced erythroleukemia differentiation.
    Marks PA; Ramsay R; Sheffery M; Rifkind RA
    Prog Clin Biol Res; 1987; 251():253-68. PubMed ID: 3481077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in gene expression associated with induced differentiation of erythroleukemia: protooncogenes, globin genes, and cell division.
    Ramsay RG; Ikeda K; Rifkind RA; Marks PA
    Proc Natl Acad Sci U S A; 1986 Sep; 83(18):6849-53. PubMed ID: 3462732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induced erythroleukemia differentiation: cellular and molecular aspects.
    Rifkind RA; Sheffery M; Marks PA
    Blood Cells; 1987; 13(1-2):277-84. PubMed ID: 3311222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induced differentiation of murine erythroleukemia cells (MELC) by polar compounds: marked increased sensitivity of vincristine resistant MELC.
    Marks PA; Michaeli J; Jackson J; Richon VM; Rifkind RA
    Prog Clin Biol Res; 1989; 316B():171-81. PubMed ID: 2616574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hexamethylene bisacetamide-induced differentiation of transformed cells: molecular and cellular effects and therapeutic application.
    Marks PA; Rifkind RA
    Int J Cell Cloning; 1988 Jul; 6(4):230-40. PubMed ID: 3047266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression of protooncogenes c-myb and c-myc during the hexamethylene bisacetamide (HMBA)-induced commitment to terminal differentiation of murine erythroleukemia cells].
    Chen ZX
    Zhonghua Zhong Liu Za Zhi; 1991 Jul; 13(4):261-4. PubMed ID: 1806345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitric oxide-releasing agents and cGMP analogues inhibit murine erythroleukemia cell differentiation and suppress erythroid-specific gene expression: correlation with decreased DNA binding of NF-E2 and altered c-myb mRNA expression.
    Suhasini M; Boss GR; Pascual FE; Pilz RB
    Cell Growth Differ; 1995 Dec; 6(12):1559-66. PubMed ID: 9019161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene expression during terminal differentiation: dexamethasone suppression of inducer-mediated alpha 1- and beta maj-globin gene expression.
    Kaneda T; Murate T; Sheffery M; Brown K; Rifkind RA; Marks PA
    Proc Natl Acad Sci U S A; 1985 Aug; 82(15):5020-4. PubMed ID: 3860841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of the c-myb, c-myc and p53 mRNA and protein levels during induced murine erythroleukemia cell differentiation.
    Richon VM; Ramsay RG; Rifkind RA; Marks PA
    Oncogene; 1989 Feb; 4(2):165-73. PubMed ID: 2648254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inducer-mediated commitment of murine erythroleukemia cells to differentiation: a multistep process.
    Chen Z; Banks J; Rifkind RA; Marks PA
    Proc Natl Acad Sci U S A; 1982 Jan; 79(2):471-5. PubMed ID: 6952199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional and post-transcriptional regulation of c-myc, c-myb, and p53 during proliferation and differentiation of murine erythroleukemia cells treated with DFMO and DMSO.
    Klinken SP; Holmes KL; Morse HC; Thorgeirsson SS
    Exp Cell Res; 1988 Oct; 178(2):185-98. PubMed ID: 2458948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of gene expression during terminal cell differentiation.
    Marks PA; Sheffery M; Rifkind RA
    Prog Clin Biol Res; 1985; 191():185-203. PubMed ID: 3901038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inducer-mediated commitment of murine erythroleukemia cells to terminal cell division: the expression of commitment.
    Murate T; Kaneda T; Rifkind RA; Marks PA
    Proc Natl Acad Sci U S A; 1984 Jun; 81(11):3394-8. PubMed ID: 6203120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between globin mRNA accumulation and commitment to terminal cell differentiation in inducer sensitive and resistant erythroleukemia variants.
    Weich N; Marks PA; Rifkind RA
    Blood; 1990 Jul; 76(2):302-6. PubMed ID: 2369636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Myb dependent pathway maintains Friend murine erythroleukemia cells in an immature and proliferating state.
    Chen J; Kremer CS; Bender TP
    Oncogene; 2002 Mar; 21(12):1859-69. PubMed ID: 11896618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and phosphorylation of the retinoblastoma protein during induced differentiation of murine erythroleukemia cells.
    Richon VM; Rifkind RA; Marks PA
    Cell Growth Differ; 1992 Jul; 3(7):413-20. PubMed ID: 1419904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of gene expression during terminal cell differentiation: murine erythroleukemia.
    Marks PA; Murate T; Kaneda T; Ravetch J; Rifkind RA
    Symp Fundam Cancer Res; 1984; 37():327-40. PubMed ID: 6084863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early protooncogene expression during hemin-induced differentiation of human erythroleukemic cells.
    Griffin MO; Nelson JC; Abraham NG
    Leuk Res; 1990; 14(11-12):997-1006. PubMed ID: 2280614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conversion of differentiation inducer resistance to differentiation inducer sensitivity in erythroleukemia cells.
    Michaeli J; Lebedev YB; Richon VM; Chen ZX; Marks PA; Rifkind RA
    Mol Cell Biol; 1990 Jul; 10(7):3535-40. PubMed ID: 1972544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.